BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16409294)

  • 21. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
    Takeshita H; Yoshizaki T; Miller WE; Sato H; Furukawa M; Pagano JS; Raab-Traub N
    J Virol; 1999 Jul; 73(7):5548-55. PubMed ID: 10364303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
    Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
    Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
    Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
    DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation.
    Park JH; Faller DV
    Virology; 2002 Nov; 303(2):345-63. PubMed ID: 12490396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations.
    Lei H; Li T; Li B; Tsai S; Biggar RJ; Nkrumah F; Neequaye J; Gutierrez M; Epelman S; Mbulaiteye SM; Bhatia K; Lo SC
    Sci Rep; 2015 Nov; 5():16706. PubMed ID: 26593963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
    Grimm T; Schneider S; Naschberger E; Huber J; Guenzi E; Kieser A; Reitmeir P; Schulz TF; Morris CA; Stürzl M
    Blood; 2005 Apr; 105(8):3263-9. PubMed ID: 15613549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.
    Zhang L; Wu L; Hong K; Pagano JS
    J Virol; 2001 Dec; 75(24):12393-401. PubMed ID: 11711629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders.
    Chuang HC; Wang JM; Hsieh WC; Chang Y; Su IJ
    Am J Pathol; 2008 Nov; 173(5):1397-405. PubMed ID: 18832568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
    Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
    Blood; 2011 Jan; 117(1):165-74. PubMed ID: 20876453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence variations between two Epstein-Barr virus LMP 1 variants have no effect on the activation of NF-kappaB activity.
    Yeh TS; Li SN; Wu CJ; Liu ST; Meng CL; Chang YS
    DNA Cell Biol; 1997 Nov; 16(11):1311-9. PubMed ID: 9407003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis.
    Coffin WF; Geiger TR; Martin JM
    J Virol; 2003 Mar; 77(6):3749-58. PubMed ID: 12610149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype.
    Kim SH; Shin YK; Lee IS; Bae YM; Sohn HW; Suh YH; Ree HJ; Rowe M; Park SH
    Blood; 2000 Jan; 95(1):294-300. PubMed ID: 10607715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cytoplasmic C-terminal domain but not the N-terminal domain of latent membrane protein 1 of Epstein-Barr virus is essential for B cell activation.
    Peng-Pilon M; Ruuth K; Lundgren E; Brodin P
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():767-77. PubMed ID: 9049322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions.
    Minarovits J; Hu LF; Minarovits-Kormuta S; Klein G; Ernberg I
    Virology; 1994 May; 200(2):661-7. PubMed ID: 8178450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.
    Shimabuku T; Tamanaha A; Kitamura B; Tanabe Y; Tawata N; Ikehara F; Arakaki K; Kinjo T
    Int J Clin Exp Pathol; 2014; 7(5):1920-34. PubMed ID: 24966902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene.
    Busson P; Edwards RH; Tursz T; Raab-Traub N
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():139-45. PubMed ID: 7844523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of latent membrane proteins in Epstein‑Barr virus-transformed lymphocytes in vitro.
    Tang Y; Luo C; Cheng A; Lu S; Xu J; Fu T; Gan R
    Mol Med Rep; 2014 Aug; 10(2):1117-21. PubMed ID: 24919846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation.
    Smith C; Wakisaka N; Crough T; Peet J; Yoshizaki T; Beagley L; Khanna R
    Blood; 2009 Jun; 113(24):6148-52. PubMed ID: 19372256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.